290 related articles for article (PubMed ID: 8226930)
1. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
Maccarana M; Casu B; Lindahl U
J Biol Chem; 1993 Nov; 268(32):23898-905. PubMed ID: 8226930
[TBL] [Abstract][Full Text] [Related]
2. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4.
Guimond S; Maccarana M; Olwin BB; Lindahl U; Rapraeger AC
J Biol Chem; 1993 Nov; 268(32):23906-14. PubMed ID: 7693696
[TBL] [Abstract][Full Text] [Related]
3. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
Loo BM; Kreuger J; Jalkanen M; Lindahl U; Salmivirta M
J Biol Chem; 2001 May; 276(20):16868-76. PubMed ID: 11278860
[TBL] [Abstract][Full Text] [Related]
4. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
Maccarana M; Casu B; Lindahl U
J Biol Chem; 1994 Feb; 269(5):3903. PubMed ID: 8106436
[No Abstract] [Full Text] [Related]
5. Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding.
Jemth P; Kreuger J; Kusche-Gullberg M; Sturiale L; Giménez-Gallego G; Lindahl U
J Biol Chem; 2002 Aug; 277(34):30567-73. PubMed ID: 12058038
[TBL] [Abstract][Full Text] [Related]
6. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
7. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.
Ashikari-Hada S; Habuchi H; Kariya Y; Itoh N; Reddi AH; Kimata K
J Biol Chem; 2004 Mar; 279(13):12346-54. PubMed ID: 14707131
[TBL] [Abstract][Full Text] [Related]
8. Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.
Rusnati M; Coltrini D; Caccia P; Dell'Era P; Zoppetti G; Oreste P; Valsasina B; Presta M
Biochem Biophys Res Commun; 1994 Aug; 203(1):450-8. PubMed ID: 8074689
[TBL] [Abstract][Full Text] [Related]
9. Characterization of fibroblast growth factor 1 binding heparan sulfate domain.
Kreuger J; Prydz K; Pettersson RF; Lindahl U; Salmivirta M
Glycobiology; 1999 Jul; 9(7):723-9. PubMed ID: 10362842
[TBL] [Abstract][Full Text] [Related]
10. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.
Ornitz DM; Herr AB; Nilsson M; Westman J; Svahn CM; Waksman G
Science; 1995 Apr; 268(5209):432-6. PubMed ID: 7536345
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis of heparin/heparan sulfate. The D-glucosaminyl 3-O-sulfotransferase reaction: target and inhibitor saccharides.
Razi N; Lindahl U
J Biol Chem; 1995 May; 270(19):11267-75. PubMed ID: 7744762
[TBL] [Abstract][Full Text] [Related]
12. A synthetic heparan sulfate pentasaccharide, exclusively containing L-iduronic acid, displays higher affinity for FGF-2 than its D-glucuronic acid-containing isomers.
Kovensky J; Duchaussoy P; Bono F; Salmivirta M; Sizun P; Herbert JM; Petitou M; Sinaÿ P
Bioorg Med Chem; 1999 Aug; 7(8):1567-80. PubMed ID: 10482449
[TBL] [Abstract][Full Text] [Related]
13. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
[TBL] [Abstract][Full Text] [Related]
14. Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain.
Feyzi E; Lustig F; Fager G; Spillmann D; Lindahl U; Salmivirta M
J Biol Chem; 1997 Feb; 272(9):5518-24. PubMed ID: 9038157
[TBL] [Abstract][Full Text] [Related]
15. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex.
McKeehan WL; Wu X; Kan M
J Biol Chem; 1999 Jul; 274(31):21511-4. PubMed ID: 10419453
[TBL] [Abstract][Full Text] [Related]
16. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
Krufka A; Guimond S; Rapraeger AC
Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
[TBL] [Abstract][Full Text] [Related]
17. Mode of interaction between pseudorabies virus and heparan sulfate/heparin.
Trybala E; Bergström T; Spillmann D; Svennerholm B; Olofsson S; Flynn SJ; Ryan P
Virology; 1996 Apr; 218(1):35-42. PubMed ID: 8615039
[TBL] [Abstract][Full Text] [Related]
18. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix.
Moscatelli D
J Biol Chem; 1992 Dec; 267(36):25803-9. PubMed ID: 1464594
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfates mediate the binding of basic fibroblast growth factor to a specific receptor on neural precursor cells.
Brickman YG; Ford MD; Small DH; Bartlett PF; Nurcombe V
J Biol Chem; 1995 Oct; 270(42):24941-8. PubMed ID: 7559620
[TBL] [Abstract][Full Text] [Related]
20. Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes.
Zhang F; Zhang Z; Lin X; Beenken A; Eliseenkova AV; Mohammadi M; Linhardt RJ
Biochemistry; 2009 Sep; 48(35):8379-86. PubMed ID: 19591432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
